Home
Improving health and reducing inequities worldwide

GLOBAL HEALTH GROUP

E2Pi News

UCSF Hosts Larry Summers Global Health 2035 Launch

The much anticipated San Francisco launch of Global Health 2035: A world converging within a generation, a report of The Lancet’s Commission on Investing in Health, took place on December 17, 2013 in Cole HallMore

Global Health 2035 In the News

The December 3, 2013 launch of Global Health 2035 was met with widespread international news coverage—print media, TV, online and radioMore

Feachem and Yamey Commissioners on New Lancet Global Health 2035 Report

UCSF Global Health Group Director, Sir Richard Feachem and Global Health Group Evidence to Policy Initiative (E2Pi) Lead, Dr. Gavin Yamey, served as Commissioners on a major new report published in The Lancet today – Global Health 2035: A World Converging Within a GenerationMore

Cervical cancer screening and treatment are neglected in low- and middle-income countries, say UCSF authors

While there have been substantial improvements in mortality rates and an increase in access to reproductive health interventions in low- and middle-income countries (LMICs), the global health community is neglecting prevention, screening, and treatment for cervical cancer in LMICs.More

E2Pi Publishes Profile on World Bank’s Role in Global Health

The World Bank is one of the most important global health financing organizations. It committed US$12 billion to the health sector between 2009 and 2012, and is the world’s second largest multilateral channel for global health funding after the Global Fund to Fight AIDS, Tuberculosis and Malaria.More

E2Pi's Gavin Yamey moderates high level panel on R&D

On December 13-14, 2012, Médecins sans Frontières (MSF) and the Drugs for Neglected Diseases (DNDi) initiative held a major international conference in New York CityMore

E2Pi’s Gavin Yamey speaks at TEDxSF

On November 10, 2012, UCSF Global Health Sciences hosted TEDx San Francisco: 7 Billion Well at the Mission Bay campus.More

E2Pi Publishes Brief on Cervical Cancer Screening

This week, the Bixby Center for Global Reproductive Health at UCSF is co-hosting a conference in Nairobi with the Kenya Medical Research Institute and the Kenyan government, called “Integration for Impact.”More

E2Pi Co-authors BMJ Editorial on HIV Pre-Exposure Prophylaxis

On 16 July 2012, the US Food and Drug Administration approved a fixed dose combination of tenofovir disoproxil fumarate and emtricitabine (TDF-FTC; Truvada) as a once daily pill for prevention of HIV infection in at risk adults.More

E2Pi Publishes 4 Articles across Three Health Journals

It has been a busy few months for E2Pi on the publication front, with 4 recent publications.More